SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Insmed Inc. (INSM)
An SI Board Since November 2000
Posts SubjectMarks Bans Symbol
136 17 0 INSM
Emcee:  SI (no user) Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
111FDA decision due very soon on approval of Iplex (formerly "Somatokine"tom r. phillips-12/9/2005
110not much anymore. why do you think it is getting interesting now? georgemopgcw-12/9/2005
109mopgcw, getting interesting. do you still watch this one? Tomtom r. phillips-12/8/2005
108Insmed Receives Approvable Letter for iPlex(TM) Tuesday September 27, 6:55 pm ETtom r. phillips-9/27/2005
107Insmed Incorporated Reports Financial Results for the Second Quarter and First Hmopgcw-8/8/2005
106FDA Extends PDUFA Date for SomatoKine to October 03, 2005 Friday June 10, 7:14 amopgcw-6/10/2005
105Tercica Seeks to Block Insmed Drug Tuesday May 31, 5:17 pm ET Tercica Seeks Comopgcw-6/1/2005
104Insmed Reports Detailed Positive Results from Its Pivotal Clinical Trial of Somamopgcw-6/1/2005
103Insmed Announces the Continuation of Litigation in the United Kingdom Tuesday Mamopgcw-5/25/2005
102Insmed Incorporated Reports Financial Results for First Quarter of 2005 Tuesday mopgcw-5/10/2005
101Insmed Announces Completion of $35 Million Financing Tuesday March 15, 4:05 pm Emopgcw-4/20/2005
100edit: About 1 year of cash to push it (and other stuff) along: Insmed Initiatesmopgcw-4/20/2005
99Patent Infringement Suit Against Insmed Dismissed Monday April 18, 3:03 pm ET mopgcw-4/19/2005
98Somatokine gets Priority Review from FDA. good timing. Tomtom r. phillips-4/13/2005
97Insmed Announces Exclusive Option Agreement with UCSF for Series of IGF-1 Receptmopgcw-3/18/2005
96Insmed Incorporated Reports Financial Results for Fourth Quarter and Twelve-Montmopgcw-3/17/2005
95Insmed Provides Response to UK Patent Lawsuit Wednesday February 16, 4:39 pm ET mopgcw-2/21/2005
94Insmed Submits New Drug Application -NDA- to Seek Regulatory Approval of SomatoKnigel bates-1/3/2005
93CROOKE GRAHAM K,Director,BUYS 5,000 ON 11/30/04 OF INSM 2004-12-02 15:06 (New Yomopgcw-12/3/2004
92Insmed Announces Expansion of Patent Portfolio in the Treatment of Diabetes Tuesmopgcw-11/11/2004
91Insmed Incorporated Reports Financial Results for Third Quarter 2004-11-08 16:25mopgcw-11/9/2004
90Insmed Raises Approximately $8.7 Million in Direct Placement of Common Stock Monmopgcw-11/8/2004
89Insmed Receives European Orphan Drug Designation for SomatoKine 2004-10-25 18:01mopgcw-10/27/2004
88Insmed Announces Initiation of Clinical Study of Small Molecule IGF-IR Tyrosine mopgcw-10/21/2004
87Insmed Reports Results from Nine Months of SomatoKine Therapy 2004-09-13 11:21 (mopgcw-9/13/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News